|
HS Code |
851094 |
| Product Name | 5-Aminomethyl-2-Bromopyridine |
| Cas Number | 41406-75-9 |
| Molecular Formula | C6H7BrN2 |
| Molecular Weight | 187.04 |
| Appearance | White to off-white solid |
| Melting Point | 59-62°C |
| Purity | Typically ≥98% |
| Solubility | Soluble in water and most organic solvents |
| Smiles | C1=CC(=NC=C1Br)CN |
| Inchi | InChI=1S/C6H7BrN2/c7-5-2-1-4(3-8)6-9-5/h1-2,6H,3,8H2 |
As an accredited 5-Aminomethyl-2-Bromopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Aminomethyl-2-Bromopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists can spend months looking for the right starting material. I’ve worked with enough halogenated pyridines to know that not all are equally useful when heading into tricky synthesis projects. 5-Aminomethyl-2-Bromopyridine stands out among the usual candidates, giving research teams a leg up when designing complex molecules. The unique arrangement—a bromine at the second position and an aminomethyl group at the fifth—brings together versatility and reactivity in a way that other molecules rarely offer.
Whether you have spent years at the bench or just started reading up on new reagents, this compound quickly reveals its strength under the right conditions. The presence of both an amino group and a reactive bromine makes it more than a one-trick pony for medicinal chemistry or material science. I remember one project where a different halogen position caused yields to nosedive during cross-coupling reactions. Once we switched to this specific model, we saw improvements not just in the product yield, but the reliability of our route as well.
Used in its standard purity levels—typically above 98% according to most reputable suppliers—5-Aminomethyl-2-Bromopyridine presents as a light yellow crystalline powder. Lab results have shown that careful storage away from excessive heat or light preserves its stability without the fuss you sometimes get from similar aromatic amines. Chemists appreciate it for this very reason: the compound holds up through several synthetic steps, letting teams plan longer, more ambitious projects.
As far as its structure goes, the specific location of both the bromine and aminomethyl side chain changes how it interacts compared to 4-bromo or 3-aminomethyl isomers. In cross-coupling chemistry, selectivity can become a sticking point. Many times, regiospecific substitution on a pyridine ring ends up being less predictable, depending on the placement of activating groups. With this molecule, you get a predictable pattern during coupling, which can reduce the number of byproducts and minimize waste—something anyone processing grams to kilograms can appreciate.
Most applications that call for 5-Aminomethyl-2-Bromopyridine relate to targeted synthesis. Pharmaceutical chemists rely on this compound to build up heterocyclic structures central to new drug candidates. The configuration of the pyridine ring—with carefully selected substitution—forms the backbone for several families of experimental therapeutics. Solid-phase synthesis often uses it for series development, especially when rapid analog construction is necessary.
My first experience with this compound came during a fragment-based drug discovery screening campaign. High-throughput runs favor small, functionalized building blocks that offer reactivity without excessive byproducts. We found that the molecule’s reactivity allowed quick exploration of chemical space around a lead series, shifting from simple Suzuki-Miyaura couplings to more complex amide formations as needed. In some routes, it even overtook older standards like 2-chloropyridine derivatives due to better compatibility with modern palladium catalysts.
Beyond pharma, some polymer and material chemists use this specific aminomethyl-bromopyridine as a monomer in functionalized polymer synthesis, especially when the final material requires both basic and halogen functionalities. The dual groups invite post-synthetic modification, letting research groups fine-tune their polymers’ physical properties in ways not possible with unsubstituted or differently substituted pyridines. Living in an era of custom-designed materials, the importance of having a flexible foundation like this cannot be overstated.
Not every bromopyridine is created equal. I’ve seen colleagues struggle with analogs where subtle differences—like swapping the aminomethyl from the fifth to the third position—scramble the entire reactivity profile. Electrophilic aromatic substitution works differently on each version of the ring. In late-stage functionalization, 5-Aminomethyl-2-Bromopyridine’s specific structure allows selectivity that cuts down on time spent on purification or reoptimization.
Some may compare it to 2-bromopyridine itself. The parent structure, while reactive, misses out on the extra handle provided by the aminomethyl group. Without that functional group, the range of transformations shrinks. Many target molecules in pharmaceuticals require a nitrogen at a specific place on the scaffold—accessing these targets using the unsubstituted version takes more steps, wastes more reagents, and often delivers lower yields. Synthetic bottlenecks carry real financial and time penalties.
Multifunctional intermediates like 3-aminomethyl-4-bromopyridine sometimes pop up in literature searches, but their different arrangement changes their behavior entirely. You can’t simply swap in a different isomer and expect predictable downstream reactions. In my own work troubleshooting failed transformations, mismatched reactivity from close analogs turned up as a key source of wasted resources. Consistency is where this model really shines, and many senior chemists come back to it for that reason alone.
Real-world labs must manage more than just reactivity. Hazards and quality come into play every day. This compound carries certain risks typical to halogenated amines. Good ventilation, gloves, and standard PPE are non-negotiable. Sensible storage away from oxidizers and acidic vapors makes a real difference in how stable and clean the compound remains. Most of the material I’ve used has lasted over a year in poly-sealed containers, kept cool and dry, with no perceptible drop in purity according to NMR and HPLC.
Waste disposal presents another challenge. The presence of both bromine and an amine group means standard organic waste streams may need extra oversight. Labs working with scaled reactions profit from checking local regulations at the outset—warding off long-term compliance headaches while saving on unplanned disposal costs.
Green chemistry principles are leaving their mark on every field, including fine chemicals like 5-Aminomethyl-2-Bromopyridine. Many modern production processes favor less hazardous solvents and catalysts that minimize byproduct formation. Over the past decade, some companies started to introduce alternative coupling reagents and recyclable catalyst systems, aiming to reduce environmental impact without sacrificing quality.
I’ve sat in meetings where colleagues debated switching suppliers based on published environmental standards rather than just price or purity. The move toward sustainable chemistry means more than just lip service—we’re seeing companies publish life cycle analyses and devote real R&D to lowering process waste. For projects aiming to scale up from grams to kilos, those changes can cut costs and improve project viability for products synthesized around this core intermediate.
Not every batch of an organic intermediate hits the lab with identical properties. Minor impurities snuck in during production can derail delicate catalytic steps downstream. Teams doing structure-activity relationship studies on new drugs come to learn that even a fraction of a percent of the wrong material leads to artifacts that muddy SAR data.
High-purity 5-Aminomethyl-2-Bromopyridine minimizes the risk of such headaches. In-house analytical checks—NMR, HPLC, sometimes mass spec—help chemists confirm quality before starting expensive, multi-step syntheses. Some research groups contract out for full certificates of analysis and cross-check spectral signatures against published literature. Several years ago, a project I observed had to repeat weeks of optimization after discovering a contaminant in a key batch; no team wants to risk repeating that experience. Regular supplier audits and maintaining direct supplier communication have kept problems at bay.
Patent strategies often hinge on access to unique intermediates and the ability to modify structures quickly to create new intellectual property. 5-Aminomethyl-2-Bromopyridine supports this workflow by allowing researchers to introduce further diversity through C-N, C-C, or C-O cross-coupling reactions. This flexibility supports patent filings on new chemical entities and process improvements, meaning that reliable access to this compound directly links to innovative progress.
Some of the most cited patents in the realm of kinase inhibitors, central nervous system drugs, and certain agrochemicals depend on pyridine backbones similar to this molecule. That wouldn’t surprise anyone who’s spent time in patent watch meetings. Having access to an intermediate standardizes the early stages of the IP creation process, while allowing rapid pivoting between analogs as patentability challenges arise.
Markets for research chemicals, especially amine-functionalized bromopyridines, carry their own ebb and flow. Demand surges when new drug classes show promise in preclinical studies or when certain catalysts become trendy in academic papers. Early in the COVID-19 pandemic, supply chains strained, and prices spiked for numerous common intermediates. Colleagues who worked through those months learned that stockpiling or advanced ordering could determine whether a project moved ahead or stalled out. 5-Aminomethyl-2-Bromopyridine saw a temporary jump in delivery times and pricing, forcing some researchers to change directions mid-project.
Today, with global supply chains stabilizing, more suppliers offer this compound with documented specifications and rapid lead times. Many labs now work with a shortlist of trusted vendors, based not just on price but documented batch-to-batch consistency and responsive customer support. These relationships help labs plan programs with fewer interruptions—especially for critical, high-value intermediates like this one.
Many research organizations operate in heavily regulated spaces where precursor chemicals draw regulatory scrutiny. 5-Aminomethyl-2-Bromopyridine does not fall under the same restrictions as certain controlled substances or dangerous precursors, but responsible labs know they should document inventory and follow safety protocols. Institutional review boards or chemical hygiene officers occasionally want to see documentation of safe storage, responsible usage, and periodic inventory of such intermediates. Proactive record-keeping supports uninterrupted research and grants compliance peace of mind to administrators.
Safety data sheets and transparent hazard communication in the lab promote understanding among new team members and interns, especially those less familiar with halogenated aromatic amines. Many labs post SOPs for handling such chemicals right above reagent storage areas—reinforcing habits that prevent accidents before they happen.
Interdisciplinary teams increasingly rely on common intermediates like 5-Aminomethyl-2-Bromopyridine to accelerate collaboration. Chemists, biologists, and engineers converge on research projects where rapid iteration and reliable access to reagents allow for quick learning and project advancement. Open science initiatives sometimes publish detailed synthetic routes and openly share structure-activity relationships, which rely on well-characterized, accessible starting materials.
A few years ago, I joined a group project where two academic labs split the work of making and screening new pyridine-based modulators for ion channel research. Raw data, spectra, and best practices on storage and handling were shared in real time over internal platforms. The ability to trust the standard of material entering both labs made collaboration efficient—revealing trends faster and guiding the whole team to meaningful conclusions. Such experiences underline how advances in chemical accessibility connect directly to breakthroughs in biology and medicine.
A chemical like 5-Aminomethyl-2-Bromopyridine serves as more than a cog in the synthetic machinery. For researchers who need flexibility in their molecular toolkits, it opens doors that might otherwise stay closed. Many high-impact projects come from that balance of having a dependable backbone while exploring new chemistry at the edges. Experience has taught me—and dozens of my colleagues—that the right intermediate, well understood and readily available, grounds even the most ambitious projects. The combination of reactive sites on this molecule enhances possibilities, rather than limiting them to narrow technical domains.
Every project demands careful attention to reproducibility and scalability. Starting with a compound that is both robust and flexible pays off when project timelines grow tight. I’ve never seen a successful drug discovery campaign that didn’t depend on reliable intermediates. The history behind this class of pyridine molecules testifies to why researchers keep coming back to them. As the chemical landscape grows more complex and standards for efficiency rise, practical, relatable molecules like this will continue to spark innovation across disciplines.
Every bottle on the lab shelf represents a chain of decisions—from sourcing and quality control to synthesis and project planning. The broad utility of 5-Aminomethyl-2-Bromopyridine grows clearer each year, as research teams map its place within bustling R&D pipelines. I’ve seen its impact directly—on improved process flows, easier IP protection, and fewer late-stage headaches. Insights gained in day-to-day chemical work make a case for embracing reliable, well-characterized intermediates. This is more than a trend: it’s a response to the real demands of scientific progress, one molecule at a time.